Sandoz Inc: Drug Recall

Recall #D-0570-2025 · 06/27/2025

Class I: Dangerous

Recall Details

Recall Number
D-0570-2025
Classification
Class I
Product Type
Drug
Recalling Firm
Sandoz Inc
Status
Ongoing
Date Initiated
06/27/2025
Location
Princeton, NJ, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
unknown

Reason for Recall

Labeling: Label Mix-Up; Some vials of Cefazolin for Injection, USP 1 gram were incorrectly labeled as penicillin G potassium for Injection, USP, 20 million Unit

Product Description

Buffered Penicillin G Potassium for Injection, USP 20,000,000 Units (20 million units), For IV use, Sterile, Rx Only, Manufactured in Austria by Sandoz GmbH for Sandoz Inc. Princeton, NJ 08540, NDC: 0781-6136-94.

Distribution Pattern

Nationwide in the USA

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.